Key facts
- This page summarizes William J. Febbo's Form 4 filing for OptimizeRx Corp (OPRX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Jun 2024, 11:41.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
The Reporting Person's prior holdings were previously inadvertently overstated by four shares.
Footnote F3
These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
Footnote F4
On April 18, 2023, the Reporting Person was granted 86,685 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
SEC remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.